Diabetes and ADHD drugs to be tested on Alzheimer's patients in new study
Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common type of dementia.
International news in seven languages
Topic
Drugs will be tested simultaneously, which it's hoped will speed up the process of finding new treatments for this common type of dementia.
After landing at Independent Film Company (formerly branded IFC) and Sapan Studio, the animated feature film “Tangles” has released a new trailer. Adapted by Leah Nelson, Trev Renney and Sarah Leavitt from Leavitt’s acclaimed graphic memoir “Tangles: A Story About Alzheimer’s, My Mother and Me,” the film tells its story through expressive, predominantly black-and-white animation. […]
Scientists have turned blood cells from an 80-year-old into neural stem cells with a molecular age of less than 20, effectively reversing more than 60 years of cellular aging in the laboratory. The discovery offers a new way to investigate how cells become younger and could help researchers better understand age-related diseases such as Alzheimer's.
Scientists have found a promising way to protect the brain from Alzheimer’s-related damage by blocking immune cells that contribute to the destruction of neurons. In mice, the treatment preserved roughly 40% more tissue in memory centers and improved memory, even without removing harmful tau protein buildup.
Scientists have uncovered an unexpected culprit behind sleep loss in Alzheimer’s disease: overactive immune cells in the brain. By temporarily removing these cells, researchers restored more than two hours of sleep per day in mice, revealing a promising new target for treatment.
Scientists have discovered why some people with a high genetic risk of Alzheimer’s remain mentally sharp into their 80s, uncovering a rare mutation that protects the brain from harmful protein buildup. The findings reveal a potential new way to prevent early brain damage and could pave the way for treatments that mimic this natural defense.
Walking just 3,000 steps a day could help slow Alzheimer’s-related brain changes, according to new research. Scientists discovered that physical activity was linked to less buildup of harmful tau proteins and nearly half the cognitive and functional decline, even in people already showing early signs of the disease. The strongest benefits appeared at 5,000 to 7,500 daily steps, suggesting that the popular 10,000-step goal may not be necessary.
A SpaceX Falcon 9 rocket created a dazzling, jellyfish-shaped glow across the eastern United States as sunlight illuminated its exhaust during an early morning launch. The mission delivered equipment and scientific experiments to the International Space Station, including research that could advance treatments for blindness, Alzheimer's, Parkinson's, and other diseases.
Scientists have discovered that a protein linked to youth helps protect the brain’s immune cells from age-related decline. Restoring the protein in older mice improved the cells’ ability to clear debris and reduced signs of inflammation, raising hopes for future treatments targeting brain aging and Alzheimer’s disease.
A rare examination of an Alzheimer’s patient’s brain revealed that regions cleared of amyloid plaques had remarkably little of the harmful tau buildup associated with memory loss, while neighboring areas showed extensive damage. The discovery suggests that removing amyloid may have lasting protective effects and could help slow Alzheimer’s progression, especially when treatment begins early.
For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results. Now, researchers at UC Santa Cruz are drawing attention to a largely overlooked peptide called P3 that could also play a role in the disease. Previously believed to be harmless, P3 can form harmful-looking protein clumps even faster than amyloid beta and may also damage brain cells.
The TV presenter says she suffered memory loss following her operation to remove a benign tumour.
Mathematics may hold unexpected clues to understanding Alzheimer’s disease. Scientists have developed a model showing how common metals like copper and zinc may influence the buildup of proteins associated with the disease, while also exploring possible ways to stop the process. The findings could help researchers identify promising strategies for preventing harmful plaque formation.
Hong Kong’s Cappu Films has taken on worldwide sales for “Banr,” Erica Xia-Hou’s Canadian-Chinese drama about a 40-year marriage tested by Alzheimer’s disease. After its world premiere in the Narrative Features lineup at the 2025 Slamdance Film Festival, the film heads to the Busan International Film Festival’s Asian Contents & Film Market, where Cappu is […]
Maricarren is the meter of things like the rest of the victims. The attacks of ETA and those of machista violence, victims of accidents and natural disasters, those of the covid and those of the ALA, Alzheimer's or evictions
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Scientists have linked a gut bacterial compound called ImP to greater Alzheimer’s risk, harmful brain protein buildup, and faster cognitive decline. The finding raises the possibility that reducing ImP in the blood could one day help slow or prevent dementia.
The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful proteins. Researchers were able to reverse some of these effects in experiments, revealing promising new targets for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
A massive MRI study found that Alzheimer’s disease, mild cognitive impairment, psychiatric disorders, and addiction are associated with distinct patterns of accelerated brain aging. The strongest effects appeared in Alzheimer’s and mild cognitive impairment, while ADHD and autism showed no significant overall difference.
Scientists found that immune cells contributing to Alzheimer’s-related brain damage may be activated in lymph nodes outside the brain before traveling into the nervous system. Blocking this pathway in mice dramatically reduced neurodegeneration and preserved cognitive abilities, pointing to a potentially more accessible treatment target.